Concepedia

Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer

Jiannan Chen, Jianhua Hu, Lili Gu, Feng Ji, Fan Zhang, Miaomiao Zhang, Jun Li, Zhengliang Chen, Longwei Jiang, Yan Zhang,

Cancer Immunology Immunotherapy · 2022 · 54 citations · 13 references

DOIFull text

Open access

Concepts

References

13

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2021 · 112.5K citations · Full text

, , +16

Cancer Statistics, 2021

Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2021 · 17.4K citations · Full text

, , +16

Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial

Gregory L. Beatty, Mark H. O’Hara, Simon F. Lacey et al. · Gastroenterology · 2018 · 500 citations · Full text

, , +12

Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers

Andrew R. Haas, János L. Tanyi, Mark H. O’Hara et al. · Molecular Therapy · 2019 · 371 citations · Full text

, , +17

Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK–modified donor T cells after allogeneic hematopoietic cell transplantation

Carolina Berger, Mary E.D. Flowers, Edus H. Warren et al. · Blood · 2005 · 338 citations · Full text

, , +8